Exposure | Abbreviations | No. of SNPs | F-statistic | R2 |
---|---|---|---|---|
Beta nerve growth factor | β-NGF | 4 | 25.72(20.83–35.43) | 0.029 |
Cutaneous T-cell attracting (CCL27) | CTACK | 10 | 39.41(20.84–139.89) | 0.097 |
Eotaxin (CCL11) | Eotaxin | 18 | 47.81(20.85–203.72) | 0.095 |
Basic fibroblast growth factor | FGF-basic | 8 | 24.77(20.79–25.40) | 0.024 |
Granulocyte colony-stimulating factor | G-CSF | 5 | 25.37(21.85–25.80) | 0.016 |
Growth regulated oncogene-α (CXCL1) | GRO-a | 7 | 100.62(21.17–248.86) | 0.166 |
Hepatocyte growth factor | HGF | 7 | 30.53(21.23–55.42) | 0.025 |
Interferon-gamma | IFN-γ | 8 | 23.69(21.47–24.99) | 0.024 |
Interleukin-1 receptor antagonist | IL-1rα | 6 | 22.84(20.89–24.25) | 0.036 |
Interleukin-1-beta | IL-1β | 4 | 22.81(21.78–23.04) | 0.027 |
Interleukin-2 | IL-2 | 7 | 23.86(20.94–27.62) | 0.045 |
Interleukin-2 receptor, alpha subunit | IL-2rα | 6 | 49.28(21.12–170.04) | 0.074 |
Interleukin-4 | IL-4 | 11 | 26.80(21.22–28.03) | 0.035 |
Interleukin-5 | IL-5 | 7 | 25.23(21.19–38.39) | 0.049 |
Interleukin-6 | IL-6 | 8 | 23.87(21.23–30.71) | 0.023 |
Interleukin-7 | IL-7 | 4 | 60.73(20.84–169.54) | 0.066 |
Interleukin-8 (CXCL8) | IL-8 | 5 | 22.77(21.10–23.85) | 0.031 |
Interleukin-9 | IL-9 | 4 | 23.50(21.54–26.37) | 0.025 |
Interleukin-10 | IL-10 | 14 | 46.17(21.26–300.09) | 0.077 |
Interleukin-12p70 | IL-12p70 | 13 | 76.58(20.89–559.19) | 0.100 |
Interleukin-13 | IL-13 | 9 | 56.52(20.88–292.36) | 0.124 |
Interleukin-16 | IL-16 | 8 | 44.72(21.99–133.68) | 0.092 |
Interleukin-17 | IL-17 | 6 | 25.45(20.95–35.94) | 0.019 |
Interleukin-18 | IL-18 | 11 | 48.72(21.83–100.11) | 0.128 |
Interferon gamma-induced protein 10 (CXCL10) | IP-10 | 7 | 24.20(21.24–26.86) | 0.044 |
Monocyte chemotactic protein-1 (CCL2) | MCP-1 | 18 | 50.77(21.45–201.44) | 0.099 |
Monocyte-specific chemokine 3 (CCL7) | MCP-3 | 6 | 25.08(20.77–26.39) | 0.121 |
Macrophage colony-stimulating factor | M-CSF | 5 | 24.30(20.96–30.98) | 0.046 |
Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | MIF | 8 | 26.56(21.25–38.68) | 0.057 |
Monokine induced by interferon-gamma (CXCL9) | MIG | 7 | 27.44 (21.62–41.56) | 0.049 |
Macrophage inflammatory protein-1α (CCL3) | MIP-1α | 2 | 22.24(21.83–22.40) | 0.012 |
Macrophage inflammatory protein-1β (CCL4) | MIP-1b | 28 | 120.68(21.55–603.64) | 0.290 |
Platelet-derived growth factor-BB | PDGF-bb | 12 | 52.83(21.17–240.19) | 0.071 |
Regulated on activation, normal T Cell expressed and secreted (CCL5) | RANTES | 9 | 26.21(20.84–34.93) | 0.064 |
Stem cell factor | SCF | 9 | 28.01(22.13–48.08) | 0.029 |
Stem cell growth factor beta | SCGF-β | 15 | 95.48(20.90–96.22) | 0.147 |
Stromal cell-derived factor-1 alpha (CXCL12) | SDF-1α | 5 | 22.42(20.91–23.36) | 0.014 |
Tumor necrosis factor-alpha | TNF-α | 2 | 22.88(22.40–23.07) | 0.013 |
Tumor necrosis factor-beta | TNF-β | 3 | 23.35(21.8–24.60) | 0.043 |
TNF-related apoptosis-inducing ligand | TRAIL | 13 | 42.63(21.28–138.48) | 0.063 |
Vascular endothelial growth factor | VEGF | 15 | 90.67(20.88–781.85) | 0.160 |
Myeloproliferative neoplasms | MPN | 5 | 64.80(45.07–117.72) | 0.001 |